(S (NP-SBJ (NN Transcription) (NN factor) (NN AP-2)) (VP (VBZ activates) (NP (NP (NN gene) (NN expression)) (PP (IN of) (NP (NN HTLV-I))))) (. .))
(S (NP-SBJ (DT The) (NN HTLV-I) (NN LTR)) (VP (VBZ contains) (NP (NP (CD three) (VBN conserved) (JJ regulatory) (NNS elements)) (VP (VBN known) (NP (-NONE- *)) (PP (IN as) (NP (NP (ADJP (CD 21) (NN base) (NN pair)) (NNS repeats)) (SBAR (WHNP-27 (WDT which)) (S (NP-SBJ-28 (-NONE- *T*-27)) (VP (VBP are) (VP (VBN required) (NP (-NONE- *-28)) (PP (IN for) (NP (NP (NN stimulation)) (PP (IN of) (NP (NN gene) (NN expression))) (PP (IN by) (NP (DT the) (NN transactivator) (NN protein) (NN tax)))))))))))))) (. .))
(S (NP-SBJ (NN Mutagenesis)) (VP (VBZ indicates) (SBAR (IN that) (S (NP-SBJ-29 (DT the) (ADJP (CD 21) (NN bp)) (NNS repeats)) (VP (MD can) (VP (VB be) (VP (VBN subdivided) (NP (-NONE- *-29)) (PP (IN into) (NP (NP (NP (CD three) (NNS motifs)) (, ,) (NP-COOD (NP (NN A)) (, ,) (NP (NN B)) (CC and) (NP (NN C)))) (, ,) (SBAR (WHNP-30 (NP (DT each)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ (-NONE- *T*-30)) (VP (VBZ influences) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN tax) (NN activation))))))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN A) (NN site)) (PP (IN in) (NP (DT the) (ADJP (CD 21) (NN bp)) (NN repeat)))) (VP (VBZ has) (NP (NP (JJ strong) (NN homology)) (PP (IN with) (NP (NP (ADJP (RB previously) (VBN described)) (VBG binding) (NNS sites)) (PP (IN for) (NP (DT the) (NN transcription) (NN factor) (NN AP-2))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD demonstrated) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (NN AP-2) (NN mRNA)) (VP (VBD was) (ADJP-PRD (JJ present) (PP (IN in) (NP (NNS T-lymphocytes))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (JJ cellular) (NNS factors)) (PP (IN from) (NP (ADJP-COOD (CC both) (ADJP (JJ non-transformed)) (CC and) (ADJP (VBN transformed))) (NNS T-lymphocytes)))) (ADVP (RB specifically)) (VP (VBD bound) (PP (TO to) (NP (NP (DT the) (NN consensus) (NN motif)) (PP (IN for) (NP (NN AP-2))) (PP (IN in) (NP (DT each) (CD 21) (NN bp)))))))))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *-31)) (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN AP-2))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (NN HTLV-I) (NN LTR) (NN gene) (NN expression))))))))) (, ,) (NP-SBJ-31 (PRP we)) (VP (VBD used) (NP (DT an) (NN AP-2) (NN cDNA)) (PP (IN in) (NP (NP-COOD (NP (NN DNA) (NN binding)) (CC and) (NP (JJ transient) (NN expression))) (NNS assays)))) (. .))
(S (NP-SBJ (NP-COOD (NP (NN Gel) (NN retardation)) (CC and) (NP (NN methylation) (NN interference))) (NNS studies)) (VP (VBD revealed) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (ADJP (RB bacterially) (VBN produced)) (NN AP-2)) (VP (VBD bound) (UCP-COOD (ADVP (RB specifically)) (CC and) (PP (IN with) (NP (JJ high) (NN affinity)))) (PP (TO to) (NP (QP (DT all) (CD three)) (ADJP (CD 21) (NN bp)) (NNS repeats)))))) (, ,) (CC and) (SBAR (IN that) (S (NP-SBJ (PRP it)) (VP (VBD required) (NP (DT the) (NN core) (NN sequence) (NN AGGC)) (PP (IN for) (NP (JJ specific) (NN binding)))))))) (. .))
(S (NP-SBJ (NP (NN Binding)) (PP (IN of) (NP (NN AP-2)))) (VP (VBD prevented) (NP (NP (DT the) (JJ subsequent) (NN binding)) (PP (IN of) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NN (ATF CREB)) (NN family))))) (PP (TO to) (NP (NP (DT an) (JJ adjacent) (JJ regulatory) (NN motif)) (PP (IN in) (NP (DT the) (ADJP (CD 21) (NN bp)) (NN repeat))))))) (. .))
(S (NP-SBJ (NP (NN Transfection)) (PP (IN of) (NP (DT an) (NN AP-2) (NN expression) (NN construct))) (PP (IN into) (NP (NNS T-lymphocytes)))) (VP (VBD activated) (NP (NP (NN gene) (NN expression)) (PP (IN from) (NP (DT the) (NN HTLV-I) (NN LTR))))) (. .))
(S-COOD (S (NP-SBJ-32 (QP (IN At) (JJS least) (CD two)) (ADJP (CD 21) (NN bp)) (NNS repeats)) (VP (VBD were) (VP (VBN required) (NP (-NONE- *-32)) (PP (IN for) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN AP-2) (NN activation)))))))) (CC and) (S (NP-SBJ (NP (NN mutagenesis)) (PP (IN of) (NP (NP (DT the) (NN AP-2) (NN consensus) (NN binding) (NNS sequences)) (PP (IN in) (NP (DT the) (ADJP (CD 21) (NN bp)) (NNS repeats)))))) (VP (VBP eliminate) (NP (DT this) (NN activation)))) (. .))
(S (-LRB- -LRB-) (NP-SBJ-103 (NN ABSTRACT)) (VP (VBN TRUNCATED) (NP (-NONE- *-103)) (PP (IN AT) (NP (CD 250) (NNS WORDS)))) (-RRB- -RRB-))
